Results 151 to 157 of about 2,782 (157)

BGM1962: A Novel Long-acting Selective Amylin Receptor Agonist for the Treatment of Obesity

Endocrine Practice
openaire   +1 more source

Development of a Novel Assay for Direct Assessment of Selective Amylin Receptor Activation Reveals Novel Differences in Behavior of Selective and Nonselective Peptide Agonists

Molecular Pharmacology
Patrick Sexton, Denise Wootten
exaly  

Development of the novel amylin and calcitonin receptor activators by peptide mutagenesis

Archives of Biochemistry and Biophysics
Sangmin Lee
exaly  

Amylin and the renin-angiotensin system: risk or opportunity in amylin-based therapy?

Lancet, The
Massimo Nardone, Mark Cooper, Patrick Rensen   +2 more
exaly  

Modulation of amylin and calcitonin receptor activation by hybrid peptides

Peptides
Sangmin Lee
exaly  

Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study

Lancet, The
exaly  

Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial

Lancet, The
exaly